Copyright Reports & Markets. All rights reserved.

Global and United States Cancer Biopsy Instruments and Kits Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cancer Biopsy Instruments and Kits Product Introduction
    • 1.2 Global Cancer Biopsy Instruments and Kits Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Cancer Biopsy Instruments and Kits Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Cancer Biopsy Instruments and Kits Sales in Volume for the Year 2017-2028
    • 1.3 United States Cancer Biopsy Instruments and Kits Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Cancer Biopsy Instruments and Kits Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Cancer Biopsy Instruments and Kits Sales in Volume for the Year 2017-2028
    • 1.4 Cancer Biopsy Instruments and Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Cancer Biopsy Instruments and Kits in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Cancer Biopsy Instruments and Kits Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Cancer Biopsy Instruments and Kits Market Dynamics
      • 1.5.1 Cancer Biopsy Instruments and Kits Industry Trends
      • 1.5.2 Cancer Biopsy Instruments and Kits Market Drivers
      • 1.5.3 Cancer Biopsy Instruments and Kits Market Challenges
      • 1.5.4 Cancer Biopsy Instruments and Kits Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Cancer Biopsy Instruments and Kits Market Segment by Type
      • 2.1.1 Cancer Biopsy Instruments
      • 2.1.2 Cancer Biopsy Kits
    • 2.2 Global Cancer Biopsy Instruments and Kits Market Size by Type
      • 2.2.1 Global Cancer Biopsy Instruments and Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Cancer Biopsy Instruments and Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Cancer Biopsy Instruments and Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Cancer Biopsy Instruments and Kits Market Size by Type
      • 2.3.1 United States Cancer Biopsy Instruments and Kits Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Cancer Biopsy Instruments and Kits Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Cancer Biopsy Instruments and Kits Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Cancer Biopsy Instruments and Kits Market Segment by Application
      • 3.1.1 Breast Cancer
      • 3.1.2 Colorectal Cancer
      • 3.1.3 Cervical Cancer
      • 3.1.4 Lung Cancer
      • 3.1.5 Others
    • 3.2 Global Cancer Biopsy Instruments and Kits Market Size by Application
      • 3.2.1 Global Cancer Biopsy Instruments and Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Cancer Biopsy Instruments and Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Cancer Biopsy Instruments and Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Cancer Biopsy Instruments and Kits Market Size by Application
      • 3.3.1 United States Cancer Biopsy Instruments and Kits Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Cancer Biopsy Instruments and Kits Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Cancer Biopsy Instruments and Kits Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Cancer Biopsy Instruments and Kits Competitor Landscape by Company

    • 4.1 Global Cancer Biopsy Instruments and Kits Market Size by Company
      • 4.1.1 Top Global Cancer Biopsy Instruments and Kits Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Cancer Biopsy Instruments and Kits Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Cancer Biopsy Instruments and Kits Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Cancer Biopsy Instruments and Kits Price by Manufacturer (2017-2022)
    • 4.2 Global Cancer Biopsy Instruments and Kits Concentration Ratio (CR)
      • 4.2.1 Cancer Biopsy Instruments and Kits Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cancer Biopsy Instruments and Kits in 2021
      • 4.2.3 Global Cancer Biopsy Instruments and Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Cancer Biopsy Instruments and Kits Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Cancer Biopsy Instruments and Kits Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Cancer Biopsy Instruments and Kits Product Type
      • 4.3.3 Date of International Manufacturers Enter into Cancer Biopsy Instruments and Kits Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Cancer Biopsy Instruments and Kits Market Size by Company
      • 4.5.1 Top Cancer Biopsy Instruments and Kits Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Cancer Biopsy Instruments and Kits Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Cancer Biopsy Instruments and Kits Sales by Players (2020, 2021 & 2022)

    5 Global Cancer Biopsy Instruments and Kits Market Size by Region

    • 5.1 Global Cancer Biopsy Instruments and Kits Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Cancer Biopsy Instruments and Kits Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Cancer Biopsy Instruments and Kits Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Cancer Biopsy Instruments and Kits Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Cancer Biopsy Instruments and Kits Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Cancer Biopsy Instruments and Kits Sales in Value by Region: 2017-2022
      • 5.3.2 Global Cancer Biopsy Instruments and Kits Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Cancer Biopsy Instruments and Kits Market Size YoY Growth 2017-2028
      • 6.1.2 North America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Cancer Biopsy Instruments and Kits Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Cancer Biopsy Instruments and Kits Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Cancer Biopsy Instruments and Kits Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Cancer Biopsy Instruments and Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Cancer Biopsy Instruments and Kits Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Cancer Biopsy Instruments and Kits Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 QIAGEN NV
      • 7.1.1 QIAGEN NV Corporation Information
      • 7.1.2 QIAGEN NV Description and Business Overview
      • 7.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Products Offered
      • 7.1.5 QIAGEN NV Recent Development
    • 7.2 Illumina, Inc.
      • 7.2.1 Illumina, Inc. Corporation Information
      • 7.2.2 Illumina, Inc. Description and Business Overview
      • 7.2.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Products Offered
      • 7.2.5 Illumina, Inc. Recent Development
    • 7.3 Becton, Dickinson and Company
      • 7.3.1 Becton, Dickinson and Company Corporation Information
      • 7.3.2 Becton, Dickinson and Company Description and Business Overview
      • 7.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Products Offered
      • 7.3.5 Becton, Dickinson and Company Recent Development
    • 7.4 Myriad Genetics
      • 7.4.1 Myriad Genetics Corporation Information
      • 7.4.2 Myriad Genetics Description and Business Overview
      • 7.4.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Myriad Genetics Cancer Biopsy Instruments and Kits Products Offered
      • 7.4.5 Myriad Genetics Recent Development
    • 7.5 Thermo Fisher Scientific, Inc.
      • 7.5.1 Thermo Fisher Scientific, Inc. Corporation Information
      • 7.5.2 Thermo Fisher Scientific, Inc. Description and Business Overview
      • 7.5.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Products Offered
      • 7.5.5 Thermo Fisher Scientific, Inc. Recent Development
    • 7.6 BIOCEPT, INC.
      • 7.6.1 BIOCEPT, INC. Corporation Information
      • 7.6.2 BIOCEPT, INC. Description and Business Overview
      • 7.6.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Products Offered
      • 7.6.5 BIOCEPT, INC. Recent Development
    • 7.7 ANGLE plc
      • 7.7.1 ANGLE plc Corporation Information
      • 7.7.2 ANGLE plc Description and Business Overview
      • 7.7.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 ANGLE plc Cancer Biopsy Instruments and Kits Products Offered
      • 7.7.5 ANGLE plc Recent Development
    • 7.8 Hologic, Inc.
      • 7.8.1 Hologic, Inc. Corporation Information
      • 7.8.2 Hologic, Inc. Description and Business Overview
      • 7.8.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Products Offered
      • 7.8.5 Hologic, Inc. Recent Development
    • 7.9 Lucence Diagnostics Pte. Ltd.
      • 7.9.1 Lucence Diagnostics Pte. Ltd. Corporation Information
      • 7.9.2 Lucence Diagnostics Pte. Ltd. Description and Business Overview
      • 7.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Products Offered
      • 7.9.5 Lucence Diagnostics Pte. Ltd. Recent Development
    • 7.10 Danaher Corporation
      • 7.10.1 Danaher Corporation Corporation Information
      • 7.10.2 Danaher Corporation Description and Business Overview
      • 7.10.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Danaher Corporation Cancer Biopsy Instruments and Kits Products Offered
      • 7.10.5 Danaher Corporation Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Cancer Biopsy Instruments and Kits Industry Chain Analysis
    • 8.2 Cancer Biopsy Instruments and Kits Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Cancer Biopsy Instruments and Kits Distributors
    • 8.3 Cancer Biopsy Instruments and Kits Production Mode & Process
    • 8.4 Cancer Biopsy Instruments and Kits Sales and Marketing
      • 8.4.1 Cancer Biopsy Instruments and Kits Sales Channels
      • 8.4.2 Cancer Biopsy Instruments and Kits Distributors
    • 8.5 Cancer Biopsy Instruments and Kits Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States Cancer Biopsy Instruments and Kits Market
      This report focuses on global and United States Cancer Biopsy Instruments and Kits market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Cancer Biopsy Instruments and Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Cancer Biopsy Instruments accounting for % of the Cancer Biopsy Instruments and Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Breast Cancer was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Cancer Biopsy Instruments and Kits market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Cancer Biopsy Instruments and Kits Scope and Market Size
      Cancer Biopsy Instruments and Kits market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biopsy Instruments and Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Cancer Biopsy Instruments and Kits market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Cancer Biopsy Instruments and Kits market is segmented into
      Cancer Biopsy Instruments
      Cancer Biopsy Kits
      Segment by Application, the Cancer Biopsy Instruments and Kits market is segmented into
      Breast Cancer
      Colorectal Cancer
      Cervical Cancer
      Lung Cancer
      Others
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Cancer Biopsy Instruments and Kits Market Share Analysis
      Cancer Biopsy Instruments and Kits market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Biopsy Instruments and Kits business, the date to enter into the Cancer Biopsy Instruments and Kits market, Cancer Biopsy Instruments and Kits product introduction, recent developments, etc.
      The major vendors covered:
      QIAGEN NV
      Illumina, Inc.
      Becton, Dickinson and Company
      Myriad Genetics
      Thermo Fisher Scientific, Inc.
      BIOCEPT, INC.
      ANGLE plc
      Hologic, Inc.
      Lucence Diagnostics Pte. Ltd.
      Danaher Corporation
      Buy now